8 results
P
patients with rare disease, caregivers
I/C
health-related quality of life (HRQOL), other chronic disease groups, general population in Hong Kong
O
lower HRQOL
P
Yu X, Xu R, Zhang Z, Yang Y, Deng F
I/C
extra-short implants (≤ 6 mm), longer implants (≥ 8 mm)
O
bone augmentation
P
South Africa, India, Turkey, Pakistan, Canada, Hong Kong, China
I/C
α-HCH, β-HCH, γ-HCH, ∑-HCH, Heptachlor, Aldrin, p,p'-DDE, p,p'-DDT, ∑-DDT, ∑-OCP, Surface water, Drinking water, Seawater, Groundwater
O
Concentration and prevalence of POPs, Carcinogenic risk, Non-carcinogenic risk
P
Chinese children under 18 years old
I/C
urban vs. rural areas, Northern China vs. Southern China, Hong Kong, Macau and Taiwan vs. mainland China
O
prevalence of refractive error (myopia, high myopia, hyperopia, astigmatism)
P
youth
I/C
treatments, existing treatments
O
behavior problems, callous-unemotional traits
P
97,213 individuals aged 40 years and older
I/C
analysis of multiple studies conducted within the Asian Eye Epidemiology Consortium (AEEC), comparison between urban and rural residents, comparison between South Asia and East Asia
O
prevalence of geographic atrophy (GA) per 1000 persons
P
adults
I/C
NAFLD incidence, females, normal weight
O
males, overweight/obese individuals, higher risk regions
P
COVID-19 patients
I/C
3-drugs-3-formulas, conventional treatment
O
duration of fever, cough, fatigue, length of hospital stay, time for nucleic acid conversion, aggravation rate, mortality, recovery rate of chest computerized tomography manifestations, total effectiveness